} ?>
huitianfu china securities precision medical theme index type initiated securities investment fund (LOF)(hereinafter referred to as huitianfu china securities precision medical index (LOF) a, code 501005) released its latest net value on may 6, up 3.02 percent.
huitianfu China securities precision medical index (LOF) a was established on January 21, 2016. the performance comparison benchmark is the yield of China securities precision medical theme index × 95% + bank RMB demand deposit interest rate (after tax) × 5%. The fund has earned -20.79 per cent since its inception, -12.18 per cent this year, 5.05 per cent in January, -22.80 per cent in one year and -56.01 per cent in three years. For nearly a year, the fund ranked 2707/3108 in its class.
The fund manager is Wu Zhenxiang. Wu Zhenxiang has managed (or intends to manage) the fund since December 17, 2015, with a gain of -20.79 during his tenure.
According to the latest periodic report, the top ten stocks of the fund are as follows:
Stock Code | Stock Name | Position Percentage | open market value (yuan) | |||
300347 | 5.68 | 1209690 | 64.295 million | |||
600276 | 5.23 | 1288491 | 59.2319 million | |||
688235 | 4.90 | 420303 | 55.5641 million | /tr>|||
300760 | Mindray Medical | 4.83 | 194247 | 54.6728 million | ||
603882 | 4.69 | 944669 | 53.1471 million | |||
<600196 | Fosun Medicine | 4.49 | 2205866 | 50.8893 million | ||
603658 | Antu Bio | 4.31% | 856809 | 48.7867 million | ||
300759 | Kanglong Chemical | 4.09% | 2274264 | <46.3268 million>/td>|||
688180 | 4.03 | 1680214 | 45.6346 million | |||
688114 | <3.96> | 759247 | 44.9019 million |
Ticker Name
Percentage Change
Inclusion Date